« FDA Approvals - Analysts foresee more boutique drugs (AP via Yahoo! News) There | Main | FDA Approves Kuvan for Treatment of Phenylketonuria (PKU) The U.S. »

Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed


Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules (Finanzen.net)
Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that the U.S. Food and Drug Administration (FDA) has issued a tentative approval letter related to the New Drug Application (NDA) for Stavzor (valproic acid delayed release ...

Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules (wallstreet:online AG)
Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that the U.S. Food and Drug Administration

pSivida Receives NASDAQ Notification Related to Minimum Bid Price (Finanzen.net)
pSivida Limited (NASDAQ: PSDV)(ASX: PSD)(FF: PSI), a global drug delivery company, today announced that on December 27, 2007, the Company received a letter from the NASDAQ Listing Qualifications Department notifying the Company that, ...
 

©2006 FDA-News.com. All rights reserved.